RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Bruce Shiramizu to Oligonucleotides, Antisense

Back to Details
This is a "connection" page, showing publications Bruce Shiramizu has written about Oligonucleotides, Antisense.
Bruce Shiramizu
Connection Strength
0.006
Oligonucleotides, Antisense
  1. McManaway ME, Neckers LM, Loke SL, al-Nasser AA, Redner RL, Shiramizu BT, Goldschmidts WL, Huber BE, Bhatia K, Magrath IT. Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide. Lancet. 1990 Apr 07; 335(8693):808-11.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support